Ashland, Inc. v. Morgan Stanley & Co., Inc.

     10-1549-cv
     Ashland Inc., AshThree LLC v. Morgan Stanley & Co.


 1                       UNITED STATES COURT OF APPEALS

 2                           FOR THE SECOND CIRCUIT

 3                              August Term, 2010

 4

 5   (Argued: March 9, 2011                     Decided: July 28, 2011)

 6                            Docket No. 10-1549-cv

 7   - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 8   ASHLAND INC., ASHTHREE LLC,
 9
10             Plaintiffs-Appellants,
11
12                  v.
13
14   MORGAN STANLEY & CO., INC.,
15
16             Defendant-Appellee.
17
18   - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
19
20   B e f o r e:   WINTER, POOLER, and HALL, Circuit Judges.

21        Appeal from an order of the United States District Court for

22   the Southern District of New York (Robert P. Patterson, Jr.,
23   Judge) dismissing plaintiffs’ complaint for failure to state a
24   claim under Rule 12(b)(6).    Appellants assert claims under

25   Section 10(b) of the Securities Exchange Act of 1934 and New York

26   common law arising from their purchase and retention of auction

27   rate securities.    We affirm the dismissal for failure to plead

28   reasonable reliance on appellee’s alleged misrepresentations.



                                        1
 1                                  CHRISTOPHER P. JOHNSON (Laurin B.
 2                                  Grollman, on the brief), Kasowitz,
 3                                  Benson, Torres & Friedman LLP, New
 4                                  York, New York, for Plaintiffs-
 5                                  Appellants.
 6
 7                                  JOHN K. CARROLL (Scott D. Musoff,
 8                                  on the brief), Skadden, Arps,
 9                                  Slate, Meagher & Flom LLP, New
10                                  York, New York, for Defendant-
11                                  Appellee.
12
13   WINTER, Circuit Judge:

14        Ashland Inc. and AshThree LLC (together, “Ashland” or

15   “appellants”) appeal from Judge Patterson’s dismissal of their

16   first amended complaint (“FAC”), which asserted claims against

17   Morgan Stanley under Section 10(b) of the Securities Exchange Act

18   of 1934 (the “Exchange Act”) and New York common law.   Appellants

19   contend that Morgan Stanley, in oral and email communications

20   with Ashland’s Assistant Treasurer, materially misrepresented the

21   liquidity of certain auction rate securities (“ARS”) and thereby

22   fraudulently induced Ashland to purchase and hold these

23   securities at a time when Morgan Stanley knew that the market for

24   ARS was collapsing.   We affirm the district court’s dismissal on

25   the ground that sophisticated investors like appellants cannot

26   plead reasonable reliance on Morgan Stanley’s alleged

27   misrepresentations in light of Morgan Stanley’s publicly-filed

28   statement explicitly disclosing the very liquidity risks about

29   which appellants claim to have been misled.

30

31

                                      2
 1                                BACKGROUND

 2        Ashland Inc. is a Kentucky-based global chemical company.

 3   It is the sole owner and operator of the special purpose entity

 4   AshThree LLC, a Delaware limited liability company.   AshThree

 5   holds the securities at issue in this case.   Appellee Morgan

 6   Stanley is a Delaware corporation with its principal place of

 7   business in New York.

 8        Ashland's relationship with Morgan Stanley began in May

 9   2007, when Ashland's long-time financial advisor, Thomas Byrne,

10   moved to Morgan Stanley.    Around that time, Byrne called

11   Ashland's Assistant Treasurer, Joseph Broce, to discuss moving

12   Ashland's investments to Morgan Stanley.    Byrne recommended

13   investing in Morgan Stanley-brokered ARS.   ARS are long-term

14   bonds and stocks whose interest rates or dividend yields are

15   periodically reset through auction.   At each auction, holders and

16   buyers of the securities specify the minimum interest rate at

17   which they want to hold or buy.   If buy/hold orders meet or

18   exceed sell orders, the auction succeeds.   If supply exceeds

19   demand, however, the auction fails and the issuer is forced to

20   pay a higher rate of interest in order to penalize it and to

21   increase investor demand.    For a more thorough explanation of the

22   mechanics of ARS, see In the matter of Bear Stearns & Co., et

23   al., SEC Release No. 8684, 88 SEC Docket 259 (May 31, 2006).

24        The ARS at issue in this matter were backed by student loan

25   obligations ("SLARS").   Byrne is alleged to have told Broce that

                                       3
 1   the ARS were "safe, liquid instruments that were suitable to

 2   [appellants'] conservative investment policies."   Byrne further

 3   represented that the SLARS would remain liquid because Morgan

 4   Stanley had never conducted a failed auction and “in the event of

 5   any instability or weakness in the market for SLARS . . . which

 6   Morgan Stanley represented to be a very ‘rare’ occurrence --

 7   Morgan Stanley's brokers and other brokers would step in and

 8   place sufficient proprietary bids to prevent auction failure and

 9   ensure the liquidity of Ashland's SLARS."    Because bid

10   information about ARS auctions was not publicly available,

11   however, appellants could not know how often Morgan Stanley had

12   intervened to ensure a successful auction.   Ashland also alleges

13   that, in fact, Morgan Stanley knew as early as August 2007 that

14   the ARS market was collapsing, in part because Morgan Stanley was

15   often required to intervene to prevent auction failure.

16        Ashland purchased SLARS through Morgan Stanley on three

17   separate occasions in 2007 -- September 25, October 2, and

18   November 29.   On the days leading up to each purchase, Byrne

19   assured Broce “that SLARS continued to be a safe, liquid

20   investment.”   Accordingly, throughout this period, Ashland placed

21   only “hold” or “hold-at-rate” orders at auctions, rather than

22   "sell" orders.1   In December 2007, Ashland learned that Goldman


          1
            A “hold” order, which is the default for current
     investors, means that the investor will continue to hold the
     securities regardless of the clearing rate. By contrast, a
     “hold-at-rate” order means that the investor will retain the

                                      4
 1   Sachs, acting as underwriter in an unrelated ARS auction, had

 2   allowed that auction to fail.   Byrne reassured Broce that this

 3   failure had no bearing on the safety of its SLARS, which were

 4   based on student loans backed by a federal guarantee, unlike

 5   those in the failed auction.    In January 2008, Ashland learned of

 6   other auction failures, but Morgan Stanley continued to assert

 7   that ARS were a safe, liquid investment.   When Ashland began

 8   placing “sell” orders around February 2008, however, it found
 9   that the market was illiquid because Morgan Stanley was no longer

10   stepping in to ensure auction success.

11        Appellants filed a complaint in the Southern District of New

12   York in June 2009, which they amended in September 2009,

13   asserting claims for violation of Section 10(b) of the Exchange

14   Act, common law fraud, promissory estoppel, breach of fiduciary

15   duty, negligence, negligent misrepresentation, and unjust

16   enrichment.   In addition to alleging that Morgan Stanley

17   misrepresented the safety and liquidity of the SLARS, the FAC

18   also alleges the following pertinent omissions.   Morgan Stanley
19   failed to disclose:   (i) how often demand failed to meet supply

20   in SLARS auctions, and consequently, how often it had to step in

21   to purchase the SLARS; (ii) that the government guarantee and

22   non-dischargeability in bankruptcy of the underlying student debt

23   obligations were unrelated to the SLARS' liquidity; (iii) the


     securities only if the clearing rate is at, or above, a rate
     specified by the investor.

                                       5
 1   relationship between fail rates, AAA ratings, and liquidity; and

 2   (iv) that it was not fully committed to ensuring liquidity of the

 3   SLARS.

 4         The district court dismissed the FAC in its entirety.

 5   Ashland Inc. v. Morgan Stanley & Co., 700 F. Supp. 2d 453, 473

 6   (S.D.N.Y. 2010).     It relied in part on the fact that in May 2006

 7   Morgan Stanley "placed a statement of its ARS policies and

 8   practices online, ‘as a result of an Order entered into between

 9   the [Securities and Exchange Commission (“SEC”)] and certain

10   active broker-dealers in the auction rate securities market.'"
11   Id. at 461.    The SEC-ordered statement included several relevant

12   disclosures.   It stated that "Morgan Stanley is permitted, but

13   not obligated, to submit orders in auctions for its own account

14   either as a bidder or a seller and routinely does so [in] its own

15   discretion."   Id.    It further explained that

16              Morgan Stanley routinely places one or more
17              bids in an auction for its own account to
18              acquire ARS for its inventory, to prevent a
19              failed auction or to prevent an auction from
20              clearing at a rate that Morgan Stanley
21              believes is higher than the market for
22              similar securities at the time it makes its
23              bid. . . . [However,] Morgan Stanley is not
24              obligated to bid in any auction to prevent an
25              auction from failing or clearing at an off-
26              market rate. Investors should not assume
27              that Morgan Stanley will do so.
28
29   Id.   It also stated that ARS holders "may be disadvantaged if

30   there is a failed auction because they are not able to exit their

31   position through the auction" and explained that "the fact that


                                        6
 1   an auction clears successfully does not mean that an investment

 2   in the ARS involves no significant liquidity or credit risk."

 3   Id.

 4          The district court concluded that the Section 10(b)

 5   securities fraud claim failed because:     (i) “hold” and “hold-at-

 6   rate” orders did not constitute a purchase or sale of securities

 7   under Blue Chip Stamps v. Manor Drug Stores, 421 U.S. 723 (1975);

 8   (ii) the FAC did not allege facts to support a strong inference

 9   of scienter as to any misrepresentations or omissions; and (iii)

10   the FAC did not allege facts to show that appellants were

11   reasonable in their reliance on any alleged misrepresentations.
12   Ashland, 700 F. Supp. 2d at 467-71.     It also dismissed the common

13   law fraud and promissory estoppel claims due to lack of

14   reasonable reliance.   Id. at 471-72.     Finally, it held that the

15   remaining state law claims were preempted by New York’s Martin

16   Act.   Id. at 472.   This appeal followed.

17                                DISCUSSION

18          We review a district court’s grant of a motion to dismiss
19   under Rule 12(b)(6) de novo, accepting as true all facts alleged
20   in the complaint and drawing all reasonable inferences in favor

21   of the non-moving party.   Chase Grp. Alliance LLC v. City of N.Y.

22   Dep’t. of Fin., 620 F.3d 146, 150 (2d Cir. 2010).     “To survive a

23   motion to dismiss, a complaint must contain sufficient factual

24   matter, accepted as true, to ‘state a claim to relief that is

25   plausible on its face.’” Ashcroft v. Iqbal, 129 S.Ct. 1937, 1949

                                       7
 1   (2009) (quoting Bell Atl. Corp. v. Twombley, 550 U.S. 544, 570

 2   (2007)).

 3   a) Section 10(b) Claim

 4        To sustain a private claim for securities fraud under

 5   Section 10(b), “a plaintiff must prove (1) a material

 6   misrepresentation or omission by the defendant; (2) scienter; (3)

 7   a connection between the misrepresentation or omission and the

 8   purchase or sale of a security; (4) reliance upon the

 9   misrepresentation or omission; (5) economic loss; and (6) loss
10   causation.”2   Stoneridge Inv. Partners, LLC v. Scientific-

          2
            As a threshold matter, appellants contend that the
     district court erred in dismissing a number of their claims
     relating to their “holding” of SLARS in reliance upon the alleged
     misrepresentations and omissions by Morgan Stanley. Typically, a
     “holder” of securities lacks standing to prosecute a claim under
     the federal securities laws. See Blue Chip Stamps v. Manor Drug
     Stores, 421 U.S. 723, 747-49 (1975) (establishing a purchaser-
     seller limit on standing); accord Merrill Lynch, Pierce, Fenner &
     Smith Inc. v. Dabit, 547 U.S. 71, 88 n.13 (2006); accord Amorosa
     v. AOL Time Warner Inc., 409 F. App’x 412, 417 (2d Cir. 2001)
     (summary order) (“[T]here is no ‘holder’ claim under federal
     securities law.”). Appellants argue that ARS differ from
     traditional securities because ARS are subject to periodic
     auctions, which require an ARS owner to make an active decision
     to hold the security before the auction. They believe this
     eliminates the concerns about “holder” standing raised in Blue
     Chip Stamps, including concerns about the lack of competent
     evidence that a holder, in fact, made an active decision to hold.
     Blue Chip Stamps, 421 U.S. at 743 (elimination of the purchaser-
     seller requirement “would throw open to the trier of fact many
     rather hazy issues of historical fact the proof of which depended
     almost entirely on oral testimony”). We need not reach the
     question of whether ARS are sufficiently distinguishable from
     other types of securities to confer standing on a holder of ARS
     to bring a claim under the securities laws, because we find that
     appellants have failed to establish that they reasonably relied
     on the alleged misrepresentations by Morgan Stanley.


                                      8
 1   Atlanta, Inc., 552 U.S. 148, 157 (2008).    Moreover, a plaintiff’s

 2   reliance on the defendant’s misrepresentation must have been

 3   reasonable in order for the claim to proceed.   See Harsco Corp.

 4   v. Segui, 91 F.3d 337, 342 (2d Cir. 1996) (collecting cases from

 5   various circuits).    "An investor may not justifiably rely on a

 6   misrepresentation if, through minimal diligence, the investor

 7   should have discovered the truth."    Brown v. E.F. Hutton Grp.,

 8   Inc., 991 F.2d 1020, 1032 (2d Cir. 1993).    Factors relevant to

 9   this analysis include:

10             (1) [t]he sophistication and expertise of the
11             plaintiff in financial and securities
12             matters; (2) the existence of longstanding
13             business or personal relationships; (3)
14             access to the relevant information; (4) the
15             existence of a fiduciary relationship; (5)
16             concealment of the fraud; (6) the opportunity
17             to detect the fraud; (7) whether the
18             plaintiff initiated the stock transaction or
19             sought to expedite the transaction; and (8)
20             the generality or specificity of the
21             misrepresentations.
22
23   Id. (collecting cases).
24
25        Appellants argue that their reliance on Broce’s
26   misrepresentations was reasonable in light of their longstanding

27   relationship with him, their repeated inquiries as to the

28   liquidity of SLARS, and the fact that auction information was not

29   publicly available.    However, the SEC-mandated statement

30   explicitly disclosed the very liquidity risks about which




                                       9
1   appellants claim to have been misled.3   Specifically, the

2   statement revealed that Morgan Stanley routinely placed bids in

3   its own auctions, in part to prevent auctions from failing.

4   Moreover, the statement was clear that Morgan Stanley did so at

5   its discretion and “[wa]s not obligated to bid in any auction to

6   prevent an auction from failing.”   In the face of this SEC-

7   mandated disclosure,4 Ashland, which admits to being “a

8   sophisticated investor,” was not justified in relying on Byrne’s

9   statements that SLARS “had no liquidity issues,” or that “in the


         3
           Appellants bring our attention to a letter amicus filed by
    the SEC in Wilson v. Merrill Lynch & Co., No. 10-1528 (2d Cir.
    argued Feb. 25, 2011). Appellants describe this letter as
    adopting their arguments with regard to whether the disclosures
    at issue in the present matter adequately described the risks of
    ARS. However, the allegations in Wilson were that Merrill Lynch
    followed a “‘uniform policy’ of placing support bids ‘if needed’
    in ‘every’ auction for which it was the sole or lead auction
    dealer.” Amicus Letter Brief for SEC at 4, Wilson, No. 10-1528
    (2d Cir. June 24, 2011). The complaint alleged that this conduct
    was manipulation designed to create an appearance of an active
    market that was in fact illusory. Id. The allegations in the
    present case are that Morgan Stanley described the SLARS sold to
    appellants as safe and liquid and that in the event of
    “instability or weakness in the market for SLARS,” Morgan Stanley
    would step in and place sufficient proprietary bids to prevent
    auction. Far from alleging that they were misled by Morgan
    Stanley’s purchasing of ARS, appellants’ complaint is in large
    part about Morgan Stanley’s failure to step in and stabilize the
    market for SLARS.
         4
           Appellants admitted, in their written submissions and oral
    argument before the district court, that they had received these
    written disclosures after their first purchase of SLARS but
    before subsequent auctions at which they placed “hold” and “hold-
    at-rate” orders. Regardless of precisely when they received the
    statement in writing, the statement was also available online,
    and appellants could have easily discovered it through minimal
    diligence.

                                   10
 1   event of ‘instability or weakness,’ Morgan Stanley would ‘come in

 2   and make a market,’ as it had always done in the past.”

 3        Nor does the alleged misrepresentation that the liquidity of

 4   SLARS was assured because of a federal government guarantee of

 5   the underlying student loans save appellants’ claim.    The value

 6   of ARS is of course affected by the riskiness of the underlying

 7   collateral.   Because the SLARS were backed by pools of guaranteed

 8   student loans, they were less risky than ARS backed by non-
 9   guaranteed loans, which have a higher risk of default.    However,

10   the appeal of ARS or SLARS is that they, in good times, provide a

11   degree of liquidity not associated with the collateral.   While

12   the reduced risk of the collateral’s default may affect the

13   liquidity of ARS, a government guarantee of the collateral does

14   not eliminate the risk of SLARS becoming illiquid.   A reasonable

15   sophisticated investor knows this because the reason for buying

16   SLARS instead of the student loans themselves is to obtain

17   greater liquidity.    Indeed, the FAC alleges that appellants

18   bought SLARS to obtain such liquidity and that Broce conceded the
19   possibility of illiquidity by promising that Morgan Stanley would

20   step in to prevent it.

21        Therefore, even accepting as true all of the facts alleged

22   in the FAC, appellants’ Section 10(b) claim fails due to their

23   inability to plead reasonable reliance on the alleged

24   misrepresentations.

25

                                      11
 1   b) Common Law Claims

 2        Ashland also appeals from the dismissal of its common law

 3   claims.   Unlike the district court, we do not address whether

 4   Martin Act preemption applies but instead affirm on appellants’

 5   lack of reasonable reliance.   See Primetime 24 Joint Venture v.

 6   Nat’l Broad., Co., 219 F.3d 92, 103 (2d Cir. 2000) (“Because we

 7   review the district court's decision to dismiss under Rule

 8   12(b)(6) de novo, we are free to affirm the decision below on

 9   dispositive but different grounds.”).

10        Reasonable reliance is a required element of common law

11   fraud, promissory estoppel, breach of fiduciary duty, and
12   negligent misrepresentation under New York law.   See Crigger v.
13   Fahnestock & Co., 443 F.3d 230, 234 (2d Cir. 2006) (common law

14   fraud); Kaye v. Grossman, 202 F.3d 611, 615 (2d Cir. 2000)

15   (promissory estoppel); King v. Crossland Sav. Bank, 111 F.3d 251,

16   257-58 (2d Cir. 1997) (negligent misrepresentation); Carr v.

17   Neilson, 909 N.Y.S.2d 387, 387 (N.Y. App. Div. 2010) (breach of

18   fiduciary duty).   We therefore affirm the dismissal of these
19   claims for the reasons stated above.    Because appellants’

20   negligence claim is virtually identical to their negligent

21   misrepresentation claim, we also affirm that dismissal.

22        Finally, appellants’ unjust enrichment claim simply does not

23   fit the facts of this case.    Under New York law, an unjust

24   enrichment claim requires a plaintiff to prove that “(1)

25   defendant was enriched, (2) at plaintiff's expense, and (3)

                                      12
 1   equity and good conscience militate against permitting defendant

 2   to retain what plaintiff is seeking to recover.”    Diesel Props

 3   S.R.L. v. Greystone Bus. Credit II LLC, 631 F.3d 42, 55 (2d Cir.

 4   2011) (internal quotation omitted).   The FAC states that

 5   “[e]quity and good conscience require disgorgement of fees earned

 6   by Morgan Stanley from Ashland’s purchases of Morgan Stanley-

 7   brokered SLARS,” because Ashland thought it was purchasing liquid

 8   investments.   However, the facts alleged are that Ashland, a

 9   sophisticated investor, failed to apprise itself of the publicly

10   disclosed riskiness of ARS as liquid investments.   There is

11   little in equity and good conscience that weighs in favor of the

12   return of the fees it paid in connection with those transactions.

13        We have considered appellants’ remaining contentions and

14   conclude that they are without merit.

15                               CONCLUSION

16        For the foregoing reasons, we affirm the district court’s

17   dismissal of appellants’ complaint.
18

19




                                     13